Prognostic and Immunological Significance of CXCR2 in Ovarian Cancer: A Promising Target for Survival Outcome and Immunotherapeutic Response Assessment

Table 2

The downregulated CXCR2-relevant genes ranked by |log2fold change|.

Genes	log2fold change	Average expression		value	FDR
PCP4	-1.372	4.022248	-5.43074	1.01-07	1.15-06	7.096412
APOA1	-1.03739	6.955593	-4.73466	3.12-06	2.29-05	3.80636
CLDN6	-0.88582	6.125029	-3.11872	0.001957	0.006165	-2.2451
FXYD4	-0.86449	1.906169	-5.00148	8.76-07	7.46-06	5.021079
FGF17	-0.83534	1.148663	-4.85379	1.78-06	1.40-05	4.341469
SMIM24	-0.82416	2.673542	-4.64089	4.80-06	3.34-05	3.393485
SIX3	-0.76623	1.360529	-3.86787	0.000129	0.000589	0.274769
MAL	-0.75402	6.521845	-3.25231	0.001249	0.004188	-1.833
FXYD7	-0.73799	2.355221	-4.24556	2.75-05	0.000153	1.734303
LHX1	-0.68835	2.827502	-2.62669	0.008976	0.02269	-3.62052
PDCL2	-0.66398	1.539734	-3.70687	0.000241	0.001012	-0.3093
NUPR2	-0.65946	4.707309	-3.53281	0.000462	0.001776	-0.91478
SAMD11	-0.64936	3.063171	-3.35658	0.00087	0.003063	-1.5
FABP6	-0.64904	2.858451	-2.96587	0.003212	0.009419	-2.69647
NPW	-0.63225	5.019634	-3.64286	0.000308	0.001243	-0.53513
CA9	-0.62153	4.176407	-3.36072	0.000857	0.003025	-1.48657
H3C11	-0.6192	2.105437	-4.39824	1.42-05	8.64-05	2.359317
PRSS1	-0.61512	3.467221	-3.50754	0.000507	0.001923	-1.00041
DEFB126	-0.61494	1.807047	-3.64746	0.000302	0.001224	-0.51901